179 related articles for article (PubMed ID: 6183037)
21. Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients.
Patel TV; Williams GH; Fisher ND
J Hypertens; 2008 Jul; 26(7):1353-9. PubMed ID: 18551010
[TBL] [Abstract][Full Text] [Related]
22. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
[TBL] [Abstract][Full Text] [Related]
23. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
Guidi E; Hollenberg NK
J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
[TBL] [Abstract][Full Text] [Related]
24. Treatment of hypertension with angiotensin converting enzyme inhibitors.
Johnston CI; McGrath BP; Matthews PG; Jackson B
Clin Exp Pharmacol Physiol Suppl; 1982; 7():135-44. PubMed ID: 6183036
[No Abstract] [Full Text] [Related]
25. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
26. Renal failure related to angiotensin-converting enzyme inhibitors.
Textor SC
Semin Nephrol; 1997 Jan; 17(1):67-76. PubMed ID: 9000551
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep.
Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA
Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038
[TBL] [Abstract][Full Text] [Related]
28. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
29. Renal mechanisms of angiotensin II-induced hypertension.
Granger JP; Schnackenberg CG
Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
[TBL] [Abstract][Full Text] [Related]
30. [The effect of activation and blockade of the renin-angiotensin system on the hypotensive activity of the cholinergic system].
Fedorov VI
Fiziol Zh SSSR Im I M Sechenova; 1992 May; 78(5):33-40. PubMed ID: 1334879
[TBL] [Abstract][Full Text] [Related]
31. Intrarenal renin-angiotensin system in renal physiology and pathophysiology.
Johnston CI; Fabris B; Jandeleit K
Kidney Int Suppl; 1993 Jul; 42():S59-63. PubMed ID: 8361131
[TBL] [Abstract][Full Text] [Related]
32. Effects of prostaglandin synthetase inhibition on captopril-induced changes in renal function in Bartter's syndrome.
Rudin A; Granérus G; Aurell M
Scand J Urol Nephrol Suppl; 1984; 79():59-62. PubMed ID: 6433438
[TBL] [Abstract][Full Text] [Related]
33. Renin vs. angiotensin-converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin.
Allan DR; Hui KY; Coletti C; Hollenberg NK
J Pharmacol Exp Ther; 1997 Nov; 283(2):661-5. PubMed ID: 9353383
[TBL] [Abstract][Full Text] [Related]
34. Converting enzyme inhibition and renal function of conscious uninephrectomized rats [correction of enzyme].
MacLaughlin M; Campisi R; Amorena C
Acta Physiol Pharmacol Ther Latinoam; 1996; 46(3):203-8. PubMed ID: 9201321
[TBL] [Abstract][Full Text] [Related]
35. Reversal by angiotensins II and III of the effects of converting enzyme inhibition on renal electrolyte excretion in rats.
Harris PJ; Munro JO
J Physiol; 1984 Jun; 351():491-500. PubMed ID: 6205144
[TBL] [Abstract][Full Text] [Related]
36. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
[TBL] [Abstract][Full Text] [Related]
37. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
[TBL] [Abstract][Full Text] [Related]
38. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-converting enzyme inhibition: renal aspect.
Hollenberg NK
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S40-4. PubMed ID: 2580175
[TBL] [Abstract][Full Text] [Related]
40. Intrarenal and systemic actions of the renin-angiotensin system. Implications for renal excretory function and sodium homeostasis.
Hollenberg NK
Contrib Nephrol; 1984; 43():102-13. PubMed ID: 6207980
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
